News | Artificial Intelligence | July 31, 2019

Artificial Intelligence Solution Improves Clinical Trial Recruitment

Study in emergency department shows automated patient screening eases enrollment

Artificial Intelligence Solution Improves Clinical Trial Recruitment

A nurse examines a patient in the Emergency Department of Cincinnati Children’s, where researchers successfully tested artificial intelligence-based technology to improve patient recruitment for clinical trials. Researchers report test results in the journal JMIR Medical Informatics. Image courtesy of Cincinnati Children’s.

July 31, 2019 — Clinical trials are a critical tool for getting new treatments to people who need them, but research shows that difficulty finding the right volunteer subjects can undermine the effectiveness of these studies. Researchers at Cincinnati Children’s Hospital Medical Center designed and tested a new computerized solution that used artificial intelligence (AI) to effectively identify eligible subjects from electronic health records (EHRs), allowing busy clinical staff to focus their limited time on evaluating the highest quality candidates.

The study is published online in JMIR Medical Informatics.1 It shows that compared to manually screening EHRs to identify study candidates, the system — called the Automated Clinical Trial Eligibility Screener (ACTES) — reduced patient screening time by 34 percent and improved patient enrollment by 11.1 percent. The system also improved the number of patients screened by 14.7 percent and those approached by 11.1 percent.

Busy emergency departments often serve as excellent locations for clinical trial coordinators to find people who may be good study candidates. According to the study’s lead investigator, Yizhao Ni, Ph.D., Division of Biomedical Informatics, ACTES is designed to streamline what often proves to be inefficient clinical trial recruiting process that does not always catch enough qualified candidates.

“Because of the large volume of data documented in EHRs, the recruiting processes used now to find relevant information are very labor intensive within the short time frame needed,” said Ni. “By leveraging natural language processing and machine learning technologies, ACTES was able to quickly analyze different types of data and automatically determine patients’ suitability for clinical trials.”

      

How it Works

The system has natural language processing, which allows computers to understand and interpret human language as the system analyzes large amounts of linguistic data. Machine learning allows computerized systems to automatically learn and evolve from experience without specifically being programmed. This makes it possible for computer programs to process data, extract information and generate knowledge independently.

The automated system extracts structured information such as patient demographics and clinical assessments from EHRs. It also identifies unstructured information from clinical notes, including the patients’ clinical conditions, symptoms, treatments and so forth. The extracted information is then matched with eligibility requirements to determine a subject’s suitability for a specific clinical trial.

The system’s machine learning component also allows it to learn from historical enrollments to improve its future recommendations, according to the researchers. Much of the analyses are handled by carefully designed AI algorithms, essentially procedures or formulas that computers use to solve problems by performing a set sequence of specified actions.

 

Advanced to Live Clinical Setting

Previously the system was successfully pilot tested in a retrospective study published in 2015 by the Journal of the American Medical Informatics Association.2 The current study tested the solution prospectively and in real time in a busy emergency department environment, where clinical research coordinators recruited patients for six different pediatric clinical trials involving different diseases.

Using the technology in a live clinical environment involved significant collaboration between data scientists, application developers, information service technicians and the end users — clinical staff.

“Thanks to the institution’s collaborative environment, we successfully incorporated different groups of experts in designing the integration process of this AI solution.” Ni said.

The researchers listed as limitations the small number of clinical trials used in the study, all from a single clinical department. They also pointed to some lingering issues involving the system’s accuracy at interpreting data. These issues will be resolved in future studies through ongoing enhancements to the technologies and also by testing the system in a wider variety of clinical departments, according to the investigators.

For more information: www.medinform.jmir.org

 

References

1. Ni Y., Bermudez M., Kennebeck S., et al. A Real-Time Automated Patient Screening System for Clinical Trials Eligibility in an Emergency Department: Design and Evaluation. JMIR Medical Informatics, July 24, 2019. DOI: 10.2196/14185

2. Ni Y., Kennebeck S., Dexheimer J.W., et al. Automated clinical trial eligibility prescreening: increasing the efficiency of patient identification for clinical trials in the emergency department. Journal of the American Medical Informatics Association, published online July 16, 2014. https://doi.org/10.1136/amiajnl-2014-002887

Related Content

Half of Hospital Decision Makers Plan to Invest in AI by 2021
News | Artificial Intelligence | August 08, 2019
A recent study conducted by Olive AI explores how hospital leaders are responding to the imperative to drive efficiency...

An example of AI-assisted automation developed by TomTec, where a deep learning algorithm automatically marks the myocardial borders and performs auto quantification This removes time consuming tasks to free up the operator to spend more time with patients and helps make exams more reproducible.

Feature | Artificial Intelligence | July 26, 2019
Intelligent software solutions (aka...
vRad Presents AI Model to Assess Probability of Aortic Dissection
News | Artificial Intelligence | July 01, 2019
vRad (Virtual Radiologic), a Mednax company recently made a scientific presentation, “Screening for Aortic Dissection...
Videos | Artificial Intelligence | June 28, 2019
This is a quick example of how artificial intelligence (AI) is being integrated on the back end of cardiac ultrasound
Third FDA Clearance Announced for Zebra-Med's AI Solution for Brain Bleed Alerts
Technology | Artificial Intelligence | June 19, 2019
Zebra Medical Vision announced it has received its third U.S. Food and Drug Administration (FDA) 510(k) clearance for...
FDA Clears Aidoc's AI Solution for Flagging Pulmonary Embolism
Technology | Artificial Intelligence | May 15, 2019
Artificial intelligence (AI) solutions provider Aidoc has been granted U.S. Food and Drug Administration (FDA)...
Overlay Init